Additional safety considerations include: Cardiovascular risk: Both medications require caution in patients with cardiovascular disease
Tarrag, M
What New Trials Suggest About Pain and Mobility May 11, 2026 Articles, Bone & Joint, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,364 views For many patients with obesity-related osteoarthritis, daily movement can feel like walking with a heavy backpack that never comes off
Tirzepatide offers significant health benefits, including up to 15% body weight reduction over 68 weeks and a convenient once-weekly administration, which can simplify a patients weight management routine
Three studies with a total of 366 exposed pregnancies and 873 comparator pregnancies found that the stillbirth estimate did not reach statistical significance (OR 2.17
This is the one finding that doesnt fold neatly into everything above, so its worth walking through